Human Prescription Drug and Biological Products--Labeling for Dosing Based on Weight or Body Surface Area for Ready-to-Use Containers--“Dose Banding”
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 2, 2023
October 2, 2023
449ec718-c571-47c0-a6d1-05154128ae01
Related Documents
Benefit-Risk Assessment for New Drug and Biological Products
Guidance DocumentOctober 17, 2023Center for Drug Evaluation and Research
Instructions for Use — Patient Labeling for Human Prescription Drug and Biological Products — Content and Format
Guidance DocumentJuly 15, 2022Center for Drug Evaluation and Research
Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products — Content and Format
Guidance DocumentDecember 10, 2014Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox